SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-24-000055
Filing Date
2024-05-29
Accepted
2024-05-29 06:29:37
Documents
15
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k-3_052924.htm 6-K 11716
2 EX-99.1 shareholder_letter.htm EX-99.1 51977
3 GRAPHIC shareholder_letter001.jpg GRAPHIC 211032
4 GRAPHIC shareholder_letter002.jpg GRAPHIC 245584
5 GRAPHIC shareholder_letter003.jpg GRAPHIC 274831
6 GRAPHIC shareholder_letter004.jpg GRAPHIC 229113
7 GRAPHIC shareholder_letter005.jpg GRAPHIC 191641
8 GRAPHIC shareholder_letter006.jpg GRAPHIC 237083
9 GRAPHIC shareholder_letter007.jpg GRAPHIC 238981
10 GRAPHIC shareholder_letter008.jpg GRAPHIC 226032
11 GRAPHIC shareholder_letter009.jpg GRAPHIC 220015
12 GRAPHIC shareholder_letter010.jpg GRAPHIC 246010
13 GRAPHIC shareholder_letter011.jpg GRAPHIC 259207
14 GRAPHIC shareholder_letter012.jpg GRAPHIC 257217
15 GRAPHIC shareholder_letter013.jpg GRAPHIC 192963
  Complete submission text file 0001395064-24-000055.txt   4238907
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 24993945
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)